recipient (5) . However, after we attempted multiple times to perform conjugation experiments, bla and bla could not be transferred, indicating their potential locations on a nonconjugative plasmid. Plasmid analysis and Southern blotting confirmed that the bla NDM-4 and bla NDM-5 genes were located on a two different plasmids of Ͼ93 kb in size. The PCR-based replicon typing method was used to identify the incompatibility group of bla NDM-4 -and bla NDM-5 -positive plasmids as previously reported (6) . The results revealed that the bla NDM-4 -positive plasmid belongs to the L/M incompatibility group and that the bla NDM-5 -positive plasmid is nontypeable. IncL/M plasmids were previously identified from different environmental and clinical isolates and are considered an emerging threat, since this group of plasmids has increasingly been identified as a source of different ␤-lactamases, including the metallo-␤-lactamase NDM-1, the class D carbapenemase OXA-48, and the extended-spectrum ␤-lactamase bla CTX-M-3 (7) .
Multilocus sequence typing (MLST) was performed according to the Klebsiella sequence typing website (http://bigsdb.web .pasteur.fr/klebsiella/klebsiella.html). MLST analysis revealed that both strains belong to sequence type 45 (ST45). Enterobacterial repetitive intergenic consensus (ERIC) sequence PCR analysis of both isolates showed different patterns, indicating their genetic diversity (data not shown). ST45 corresponds to the ST of the most recently identified NDM-5-positive K. pneumoniae strain identified in Australia (8) and the ST of the NDM-1-positive K. pneumoniae strain identified in Turkey (9). However, it does not correspond to the ST of the NDM-5-positive K. pneumoniae strain, which was ST147, from a patient transferred from the United Arab Emirates to South Korea (2). It has previously been suggested that the Middle East, which is geographically close to the Indian subcontinent, is another reservoir of NDM-producing Enterobacteriaceae (3). Our findings support this proposition, because neither patient had a history of travel, suggesting that NDM-4 and NDM-5 were hospital acquired and autochthonous in Egypt.
Our study confirms the emergence of NDM-4-and NDM-5-producing bacteria in the African continent after their recent identification in Cameroon and Algeria, respectively (3, 10) . The worldwide emergence of NDM-4 and NDM-5 producers is quite alarming, particularly when the increased carbapenemase activity of NDM-4 and NDM-5, compared with that of NDM-1, is taken into account. Moreover, the cooccurrence of two highly resistant bacteria in the same patient is extremely worrisome because it might lead to therapeutic failure and death. Therefore, it is imperative that the relevant medical authorities consider the prevalence of NDM enzymes within the community to monitor future trends and prevent spread into epidemic clonal lineages.
Nucleotide sequence accession numbers. The nucleotide sequences of the bla NDM-4 -and bla NDM-5-containing K. pneumoniae strains have been deposited in the DDBJ/GenBank/EMBL database under accession no. LC145700 and LC146472, respectively. 
